EU regulator extends review of Pfizer/Wyeth deal

BRUSSELS, June 30 (Reuters) - European Union antitrust authorities on Tuesday extended the deadline for their review of U.S. drugmaker Pfizer's (PFE.N) $68 billion plan to take over rival Wyeth WYE.N.

The European Commission extended the review deadline to July 20 from July 6 to consider remedies offered to address competition concerns, a daily list of planned mergers being scrutinised by the EU executive said.

Double click on the newslinks below for the relevant topics:

[EU-REGS-RTRS-LEN] For stories on competition issues

[EU-REGS-AID-BACT-RTRS-LEN] For stories on state aid, M&As (Reporting by Bate Felix, editing by Dale Hudson)